Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial

INTRODUCTION: Survival in men diagnosed with de novo synchronous metastatic prostate cancer has increased following the use of upfront systemic treatment, using chemotherapy and other novel androgen receptor targeted agents, in addition to standard androgen deprivation therapy (ADT). Local cytoreduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Connor, Martin John, Shah, Taimur Tariq, Smigielska, Katarzyna, Day, Emily, Sukumar, Johanna, Fiorentino, Francesca, Sarwar, Naveed, Gonzalez, Michael, Falconer, Alison, Klimowska-Nassar, Natalia, Evans, Martin, Naismith, Olivia Frances, Thippu Jayaprakash, Kamalram, Price, Derek, Gayadeen, Shiva, Basak, Dolan, Horan, Gail, McGrath, John, Sheehan, Denise, Kumar, Manal, Ibrahim, Azman, Brock, Cathryn, Pearson, Rachel A., Anyamene, Nicola, Heath, Catherine, Shergill, Iqbal, Rai, Bhavan, Hellawell, Giles, McCracken, Stuart, Khoubehi, Bijan, Mangar, Stephen, Khoo, Vincent, Dudderidge, Tim, Staffurth, John Nicholas, Winkler, Mathias, Ahmed, Hashim Uddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908915/
https://www.ncbi.nlm.nih.gov/pubmed/33632752
http://dx.doi.org/10.1136/bmjopen-2020-042953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908915/
https://www.ncbi.nlm.nih.gov/pubmed/33632752
http://dx.doi.org/10.1136/bmjopen-2020-042953

Ejemplares similares